Scindo
PrivateLast Round
Seed
Sep 23, 2025
Total Funding Raised
$5.65M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Scindo operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in September 2025.
Scindo is a biotechnology company that has developed an AI-powered platform for enzyme discovery and engineering to transform renewable and recycled feedstocks into high-value bio-based ingredients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing, Circular Economy
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Scindo Comparables
Compare Scindo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| digzyme Inc. | 83% | |
| Biomatter | 81% | |
| ErebaGen | 80% |
For institutional investors. Book with your work email.
Scindo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 23, 2025 | ||||
| Accelerator | Jun 11, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Scindo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Farvatn Venture | Seed |
| SynBioVen | Seed |
| IndieBio | Accelerator |
| Clay Capital | Seed |
| AgFunder | Seed |
| Kadmos Capital | Seed |
| Savantus Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 148% MoM, reaching 2.1K.
- Dec 1, 2025
CEO Gustaf Hemberg to speak at SynbiTECH 2025 on December 1, 2025.
For institutional investors. Book with your work email.
Scindo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Scindo's valuation, stock price, and market status.
Is Scindo a public or private company?
Scindo is a private company.
What is the current stock price of Scindo?
Scindo is a private company, so its shares have no public market price. Caplight tracks Scindo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Scindo worth (valuation)?
Valuation information for Scindo is not publicly available.
Can I buy Scindo stock?
Scindo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Scindo's last funding round?
Scindo's most recent funding round was Seed on September 23, 2025.
Who are the main investors in Scindo?
Key investors in Scindo include IndieBio, Clay Capital, Kadmos Capital, Clay Capital.
Will Scindo IPO soon?
No public IPO plans have been announced for Scindo.
How can I track Scindo secondary market activity?
Caplight tracks bids, offers, and trades in Scindo's shares on secondary markets.